Haemostatic Biomarkers for Prognosis and Prediction of Therapy Response in Patients With Metastatic Colorectal Cancer

Thrombosis Research - United Kingdom
doi 10.1016/j.thromres.2020.01.002
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV

Related search

Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma

2020English

Therapy for Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2006English

Current and Emerging Biomarkers in Metastatic Colorectal Cancer

Current Oncology
Oncology
2019English

Emerging microRNA Biomarkers for Colorectal Cancer Diagnosis and Prognosis

Open Biology
BiochemistryImmunologyGeneticsMolecular BiologyNeuroscience
2019English

Potential Prognostic Factors for Predicting the Chemotherapeutic Outcomes and Prognosis of Patients With Metastatic Colorectal Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2019English

Significance of Inflammation-Based Indices in the Prognosis of Patients With Non-Metastatic Colorectal Cancer

Oncotarget
Oncology
2017English

The Significance of Tumor-Associated Immune Response in Molecular Taxonomy, Prognosis and Therapy of Colorectal Cancer Patients

Annals of Translational Medicine
Medicine
2016English

Trefoil Factor Family (TFF) Proteins as Potential Serum Biomarkers in Patients With Metastatic Colorectal Cancer.

Neoplasma
Cancer Research
2015English

Improving CT Prediction of Treatment Response in Patients With Metastatic Colorectal Carcinoma Using Statistical Learning Theory

BMC Genomics
BiotechnologyGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy